MEDICOX Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 6,755.32 million compared to KRW 5,839.84 million a year ago. Net loss was KRW 5,966.22 million compared to KRW 14,762.38 million a year ago. Basic loss per share from continuing operations was KRW 199 compared to KRW 737 a year ago. Diluted loss per share from continuing operations was KRW 199. Basic loss per share was KRW 199 compared to KRW 737 a year ago.
For the nine months, sales was KRW 364.78 million compared to KRW 0.00048 million a year ago. Net loss was KRW 19,034.59 million compared to KRW 22,197.15 million a year ago. Basic loss per share from continuing operations was KRW 681 compared to KRW 1,125 a year ago. Diluted loss per share from continuing operations was KRW 681 compared to KRW 1,125 a year ago. Basic loss per share was KRW 681 compared to KRW 1,125 a year ago.